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ABSTRACT 
Objective 
Cancer has been reported to trigger symptoms of post-traumatic stress disorder (PTSD) in a 
substantial proportion of individuals. Despite the significant burden associated with these 
symptoms, there are as yet no therapeutic guidelines. This systematic review aims to evaluate 
the effectiveness of interventions for cancer-related post-traumatic stress in order to provide 
an evidence base for developing appropriate clinical practice. 
Methods 
Databases searched until April 2018 included, Psych INFO, EMBASE, Medline and the 
Cumulative Index to Nursing and Allied Health Literature (CINAHL). No restrictions to 
study design were applied. Participants aged 18 years or older who received their cancer 
diagnosis in adulthood and had symptoms of cancer-related PTSD were included. Due to 
significant clinical heterogeneity, a meta-analysis was not performed. 
Results 
Of 508 unique titles, eight studies met study inclusion criteria: five RCTs, one before-and-
after study, one case series and one case study. Interventions were predominately 
psychological and were administered to patients with a range of cancer types. Eye Movement 
Desensitisation and Reprocessing and cognitive behavioural therapy-based interventions were 
associated with reduced symptomatology, however, overall the methodological quality of 
studies had limitations. 
Conclusions 
At present there is only weak evidence available for the effectiveness of psychological 
interventions in reducing symptoms of cancer-related PTSD. The majority of interventions 
were administered to all cancer patients regardless of whether they showed pretreatment 
levels of post-traumatic stress. Future studies would be better targeted towards patients with a 
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diagnosis of cancer and who have significant levels of cancer-related post-traumatic 
symptoms. Higher quality trials are also needed before treatment recommendations can be 
made. 
 
Keywords: cancer, oncology, PTSD, traumatic stress, systematic review, psychological 
interventions 
BACKGROUND 
The diagnosis and treatment of cancer is acknowledged as a potential stressor that can lead to 
significant psychological distress including symptoms of depression and anxiety, as well as 
symptoms of post-traumatic stress. Experiencing distress in response to cancer is common 
and can occur at critical times throughout the course of the disease. Patients’ emotional 
reactions may range from normal feelings of fear and vulnerability to more rare but disabling 
psychopathologies. Studies have repeatedly demonstrated that a proportion of cancer patients 
exhibit symptoms of cancer-related post-traumatic stress1. 
According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-V), post-
traumatic stress disorder (PTSD) is a psychiatric condition that can occur following exposure 
to one or more traumatic events that involve the threat of serious injury or death to oneself or 
others (Criterion A) 2. Four core symptom clusters comprise PTSD in accordance with DSM-
V: involuntary re-experiencing of stressful events (Criterion B), avoidant behaviour 
(Criterion C), negative thoughts and cognitive appraisals (Criterion D), and hyper-arousal or 
reactivity (Criterion E). In order for the diagnosis of PTSD to be met, these symptoms need to 
be present for more than a month (Criterion F) and to cause significant impairment in 
functioning (Criterion G). Prevalence estimates of cancer-related PTSD range between 7-
14% 3, with an additional 10-20% of patients experiencing sub-syndromal post-traumatic 
stress symptoms (i.e. PTSS) 4 5. Both PTSD and PTSS have been associated with increased 
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distress and impaired quality of life 6, and have been reported in newly-diagnosed patients as 
well as in long-term survivors 7. Furthermore, PTSD as a comorbidity has been shown to have 
a negative impact on health-related outcomes such as drug adherence and morbidity and 
mortality rates 8 9.  
As Cordova et al explained in their recent qualitative review of the cancer-related PTSD 
literature, the applicability of a PTSD diagnosis to distress arising from cancer has not been 
without controversy10. In contrast to DSM-IV, the revised PTSD diagnostic criteria in DSM-
V suggest that a life-threatening medical condition, such as cancer, does not necessarily 
constitute a traumatic event if no sudden, catastrophic events have occurred. The revised 
PTSD criteria draw attention to the importance of carefully considering differential diagnoses 
such as that of an adjustment disorder. The use of the latter diagnosis might be more 
appropriate for patients presenting with sub-syndromal cancer-related PTSD symptoms, as 
well as for those whose experience of cancer does not qualify as traumatic based on the 
current diagnostic criteria 3,10,11. Arguably, this is a complex diagnostic issue, which, of 
course, has implications for how cancer-related PTSD is treated.   
Advances in treatments and increased public awareness mean that more people than ever live 
with and beyond cancer. At the same time, the number of new cases worldwide is expected to 
rise by over 70% in 2030 12. Therefore, as the number of people diagnosed with cancer 
increases and cancer survivorship improves, cancer-related PTSD becomes a more prominent 
issue and thus providing for cancer patients’ physical and psychological needs becomes 
increasingly important. In contrast to the considerable body of literature investigating the 
prevalence and detection of cancer-related PTSD symptoms, work focusing on interventions 
targeting clinical and/or subclinical cancer-related PTSD is sparse. Due to the aforementioned 
significant impairments associated with cancer-related post-traumatic stress , it is important 
to assess the effectiveness of psychological treatments in this group of patients, as well as to 
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take into account how therapies may have a different effect on syndromal and sub-syndromal 
cancer-related PTSD symptoms. Evidence-based treatments such as Eye Movement 
Desensitization and Reprocessing (EMDR) therapy and cognitive-behavioural therapy (CBT) 
are available for PTSD and, indeed, there have been promising reports of their effectiveness 
in cancer patients 13 14,15.  
To the best of our knowledge, only one review to date has examined the evidence base for 
psychological interventions targeting symptoms of cancer-related post-traumatic stress. 
Nenova et al examined the efficacy of CBT-based interventions  however they did not 
explicitly include studies where patients were screened for baseline PTSD symptoms13. In 
this instance, interventions were delivered to patients united by a diagnosis of cancer and not 
to those patients presenting with symptoms of cancer-related PTSD.  Interestingly, the 
authors did acknowledge that that the effectiveness of interventions may have been dependent 
on participants’ baseline levels of distress13. Furthermore, Nenova’s work is limited to 
literature published between 1994 and 2010 and, therefore, we believe that our review 
provides a timely summary of the most recent literature in the field. 
The aim of the present study was to review systematically the evidence on the effectiveness 
of interventions for reducing symptoms of cancer-related post-traumatic stress. The current 
study extends previous work by focusing exclusively on cancer patients suffering from 
cancer-related post-traumatic stress and by summarising the evidence for several types of 
interventions 13.  
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MATERIAL AND METHODS 
Search strategy and selection criteria  
A qualitative systematic review examining existing primary studies of interventions for 
cancer-related post-traumatic stress was performed in accordance with the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The 
review was registered on the Prospero database with the registration number 
CRD42017069394.  
Inclusion criteria were organised based on the PICO (i.e. Patient, Intervention, Comparison, 
Outcome) reporting structure. The population of interest was cancer patients with cancer-
related PTSD/PTSS, who were aged 18 years or more, and who had received their cancer 
diagnosis as adults. Studies with a subgroup analysis of cancer patients scoring highly on 
PTSD measures were included in this review. As there are low numbers of interventional 
studies, no restrictions were made to specific cancer types. No restrictions were applied to 
study design due to the paucity of studies in this field. Similarly, no limits were applied to 
intervention type, with both psychological and pharmacological interventions included. 
Eligibility criteria extended to individual, couple or group settings and all modes of delivery 
(in person, virtual or over the phone). The primary outcome was cancer-related post-
traumatic stress determined by either structured interview using the Structure Clinical 
Interview for DSM IV/V (SCID)  2 or the Clinician-Administered PTSD Scale (CAPS) 16, or 
by validated PTSD self-report scales which included the Impact of Events Scale (IES) 17, 
revised Impact of Events Scale (IES-R) 18, the Posttraumatic diagnostic stress scale (PDS) 19, 
PTSD Symptom Scale (PSS) 20, Short Post-Traumatic Stress Disorder Rating Interview 
(SPRINT) 21, or the PTSD Checklist (PCL-C) 22. Studies were excluded if assessment of 
cancer-related PTSD symptoms was based on non-validated instruments, or on a PTSD 
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measure combined with non-PTSD measures (such as depression or anxiety scales) with no 
outcome data presented for those scoring highly specifically on PTSD measures. No 
publication date or status restrictions were applied.  Studies were limited to English language 
publications only. 
Studies were identified using the online electronic databases Medline, EMBASE, 
PSYCHInfo, and CINAHL. The search was done by LD and EM on the 10th of April 2018. 
The search strategy used variations for the terms “PTSD”, “cancer” and “intervention”. The 
full list of search terms is provided in Appendix 1. Reference lists of papers looking at 
cancer-related post-traumatic stress were manually scanned. Two authors (LD, EM) 
independently screened all titles and abstracts of the identified articles and when eligibility 
was established, the full text was read. Any discrepancies regarding inclusion were resolved 
by discussion with a third author (AK).  
Data analysis  
Two authors (LD and EM) independently performed the data extraction for eligible papers 
using a data extraction form and any disparities were settled by consensus. The following 
variables were extracted:  
 General: author, year, title, journal, country, total number of participants, study design 
 Participants: gender, age range, ethnicity, cancer type, socioeconomic status, PTSD 
diagnostic criteria 
 Intervention: setting, category of intervention (psychological, pharmacological), 
specific name of intervention, delivery of intervention, duration of intervention, 
frequency of intervention, point of intervention onset (at diagnosis, during treatment, 
at treatment completion, at survivorship stage), follow-up, randomisation, blinding 
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 Results: Main outcome measures, secondary outcome measures, narrative findings, 
adherence levels, patient satisfaction, effect sizes 
Risk of bias was assessed for each study using study design specific validated tools. The 
Cochrane risk of bias tool was used for RCTs, the NIH Quality Assessment Tool for Case 
Series Studies, and the NIH Quality Assessment Tool for Before-After (Pre-Post) Studies 
With No Control Group. As the included RCTs involved behavioural interventions, the 
domain of participant and personnel blinding of the Cochrane Risk of Bias Tool was assessed 
using proposed criteria established for such study types 23. No formal assessment of quality 
tool was identified for case studies.  
Due to significant clinical (i.e. variability in participant characteristics, intervention 
components and outcome measures) and methodological (i.e. variability in study designs) 
heterogeneity across studies a meta-analysis could not be performed. Since our primary 
interest is to inform clinical practice, we report the main findings stratified by intervention 
category: EMDR, CBT-based and other.  
RESULTS 
Our electronic search yielded 508 unique papers. From this, 74 were included after the title 
search. Following abstract screening this number was reduced to 22 eligible papers for full 
text review. A further 16 papers were identified by reference chaining (Figure 1). Eight 
published papers entered this review. Papers were excluded either because no subgroup 
analysis was performed for participants scoring highly on PTSD measures, or due to using a 
combination of PTSD and non-PTSD tools without reporting specifically on patients scoring 
highly on the PTSD measures, or because non-validated PTSD tools were used (Appendix 2).  
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The types of interventions, settings, patient characteristics, measures of post-traumatic stress, 
and the key narrative findings are reported in Table 1. Of the eight eligible papers, there were 
five RCTs 14 24 25,26 27, one case series 28, one case study 29, and one before-and-after study 15.  
The interventions broadly fell into three main groups. Two studies investigated the effects of 
EMDR 14 15, four looked at CBT-based treatments 24 26 28 24 and two were interventions not 
belonging to either of these categories 26,27. There were considerable differences in participant 
characteristics, intervention delivery, follow-up protocols and outcome assessment across the 
studies. The total duration of intervention varied considerably with the shortest duration of 
treatment lasting three days through to the longest lasting 12 months.  
Most studies contained a mixture of active cancer treatment and follow-up patients 24,28 27, two 
studies involved participants who had completed their cancer treatment 26 29, a single study 
looked only at newly diagnosed patients 25 and two studies investigated the effects of cancer 
status on the efficacy of the cancer-related PTSD intervention 14,15 28. Three studies focused on 
breast cancer patients 26,27 28, two covered mixed tumour groups 14 15, two focused on 
haematological malignancies 29 24, and one on head and neck cancer 25.  
The included studies were generally of low methodological quality (Table 2). Within the 
RCTs, there was frequent failure to disclose randomisation methods and allocation 
concealment. Blinding of participants and personnel was either not specified or participants 
were informed of whether they had been allocated to the intervention or control group. 
Another common methodological flaw was failure to account for cases lost to follow-up. No 
studies reported reliable change indices and only 2 studies included effect sizes.  Publication 
bias could not be assessed due to the small number of studies included in this review (i.e. 
<10). 
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EMDR 
Capezzani’s small RCT (n = 31) compared the effects of EMDR against CBT in a group 
predominately composed of women with a range of cancer types 14. Patients in the follow-up 
phase of their cancer management were randomised to receive either EMDR or CBT, 
whereas those in active treatment were automatically assigned to EMDR with no control 
group. EMDR was superior to CBT in reducing PTSD scores in follow-up patients. 
Secondary analysis showed that EMDR was equally effective in reducing PTSD 
symptomatology both for patients undergoing treatment as well as for those in follow up.  
Jarero et al evaluated the effects of a group-variant of EMDR in a population of women with 
mixed cancer types living in sheltered housing in Mexico 15. The intervention was delivered 
over the shortest time period of all studies in this review with a total treatment duration of 
just three days. In keeping with Capezzani’s findings, the authors concluded that EMDR was 
effective in reducing PTSD symptoms for both active and follow-up cancer patients and this 
effect was maintained at 90 days.  
CBT 
In their RCT of head-and-neck cancer patients, Kangas et al found that CBT, when compared 
with supportive counselling, was associated with a clinically significant improvement in 
PTSD scores in the subgroup of patients with clinical or subclinical baseline levels of PTSD 
25. In the largest study included in this review, DuHamel et al found that participants 
undergoing a ten session, telephone-delivered CBT (T-CBT) were less likely to meet 
diagnostic criteria for PTSD at both six and 12 months follow up assessments 24. Although T-
CBT reduced total PTSD symptom scores, it was effective for intrusive thoughts and 
avoidance but not for numbing and hyperarousal. It should be noted that the control group 
was an assessment-only condition.  
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In a case series of five women, Beatty and Koczwara concluded that CBT delivered as a 
stress management group programme was effective at reducing PTSD symptoms; at one 
month follow-up, two patients had achieved recovery, one patient had improved and the other 
two patients had deteriorated to baseline levels 28. Finally, DuHamel reported that a trauma-
focused intervention (a variant of CBT that has been found to be effective in reducing PTSD 
symptoms after trauma  resulted in recovery from clinically significant post-traumatic stress, 
however this was based on the findings from a single patient29. 
Other  
Marcus et al assessed the efficacy of telephone-counselling combined with a resource booklet 
compared to a resource booklet alone in 304 women with breast cancer26. Based on a 
subgroup of patients who exceeded the normative threshold for intrusive symptoms, the 
combined intervention yielded a 50% reduction in cancer-related distress whereas patients in 
the control group did not improve 26. It is not clear why the authors do not use the IES total 
score in their analysis but only report on the intrusion subscale scores.  
Levine’s study assessed the effectiveness of a complementary/ alternative oriented 
intervention (CAM) involving a combination of yoga, meditation, imagery & expressive arts. 
In a subgroup of patients with PTSD at baseline (n = 28), they found that CAM was less 
effective at improving re-experiencing and avoidance PTSD symptoms when compared to a 
standard support group 27. However, both the CAM and the support group were effective in 
reducing symptoms of arousal.  
DISCUSSION 
Only eight studies met the criteria for inclusion in this review. This small number suggests 
that the literature on the treatment of post-traumatic stress occurring as a result of cancer is 
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scarce, despite the substantial burden on those living with and beyond cancer. The majority of 
the studies focused on CBT-based interventions with a couple of studies examining the 
effects of EMDR and the rest evaluating the effectiveness of counselling and complementary 
therapy.  
EMDR was found to be effective in both active and follow-up cancer patients, and more 
effective than CBT in follow-up patients, however the small sample sizes (n = 55) in the 2 
included studies should temper such conclusions. To the best of our knowledge, no other 
studies have investigated EMDR in cancer patients despite increasing evidence that EMDR is 
an effective therapeutic strategy for clinical PTSD in other patient groups such as those 
suffering from chronic pain and cardiac events 30 31. 
CBT delivered in person, in a group or individually, or over the telephone, was associated 
with reductions in PTSD symptoms in all four studies in line with the findings of Nenova’s 
review 13. The positive effects were maintained in the follow up assessments with the 
exception of a single study which found that two of the five participants who received group 
stress management CBT deteriorated at 1 month follow-up in comparison to post-treatment 
levels 28. This should be interpreted with caution given the limitations of a case series design.  
Complementary/alternative oriented intervention was effective in reducing levels of cancer-
related traumatic stress but not as effective as the control support group 27. The only study 
assessing a telephone counselling intervention reported significant improvements at 18 
months after study enrolment for patients with symptoms of intrusion suggestive of the need 
for clinical referral 26.   
Interventions did not always act uniformly on key features of cancer-related PTSD. 
Telephone CBT was more effective in reducing intrusive thoughts and avoidance than 
symptoms of hyper-arousal and numbing 24. Similarly, standard support group care improved 
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re-experiencing and avoidant symptoms whereas complementary treatment did not change 
these parameters 27. Both treatments were effective for arousal and overall PCL-C scores. 
This may be the case with respect to the effects of group stress management CBT as well; 
beneficial effects of CBSM have been previously found specifically for intrusive symptoms 2. 
Evidence from studies assessing the efficacy of PTSD treatments in non-cancer trauma 
populations suggests that interventions may act differentially resulting in improvements for 
specific symptom domains rather than for total PTSD symptoms 33. This is perhaps not 
unexpected in cancer-related PTSD symptoms, given that the definition is rather 
heterogeneous (e.g. presence of several different symptom clusters, degrees of symptom 
severity and chronicity and overlap between symptoms of PTSD and those of other mood and 
anxiety disorders)34. This makes the evaluation of treatment outcomes challenging. 
Furthermore, given that the clinical picture in cancer-related PTSD is often complex, correct 
clinical formulation can be challenging. This is important, as effective treatment is contingent 
upon correct application of trauma-focused techniques emerging from the clinical 
formulation. A more precise description of the nature and course of cancer-related PTSD will 
enable a better understanding of this condition which in turn may promote more effective 
treatment planning and delivery.  
Many studies did not meet our inclusion criteria after full-text screening as a result of failure 
to identify participants who suffered from symptoms of post-traumatic stress. This is 
representative of much of the work into treatments for cancer-related post-traumatic stress, 
where patient inclusion criteria includes a diagnosis of cancer rather than the existence of 
cancer-related post-traumatic stress symptoms. The importance of baseline screening was 
highlighted in Nenova et al’s systematic review of CBT-based interventions 13. They found 
that 68% of included studies did not show an effect on cancer-related PTSD symptoms. 
However, when they examined the subset of studies that specifically screened for highly 
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distressed patients, the interventions were found to be effective. In fact, in the study of phone 
counselling included here, no significant effect of telephone counselling on PTSD symptoms 
was identified until patients were dichotomised into high and low levels of baseline PTSD 26. 
This yielded dramatically different results with significant improvement in PTSD symptoms 
for those scoring highly for intrusion at baseline, compared to no improvement in those with 
low baseline scores. We were unable to make a distinction between PTSD and PTSS in this 
review due to the small number of studies available, however, it would be of interest to 
explore whether interventions vary in efficacy depending on levels of PTSD 
symptomatology. This becomes increasingly important given that, depending on symptom 
severity and chronicity, cancer-related PTSD/PTSS can be complex to differentiate from 
other common emotional responses to cancer such as fear of recurrence and adjustment 
disorder.  
Another methodological limitation that we encountered was the use of diverse measures to 
screen for symptoms of PTSD. Studies often used non-validated measures or combined 
validated PTSD measures with scales assessing other outcomes such as depression or overall 
psychological distress. Assessing the efficacy of an intervention when it is delivered to 
patients without the condition it is intending to treat, may underestimate its beneficial effects. 
Consequently, delivering treatments for cancer-related PTSD when they have been validated 
only in cohorts including individuals not suffering from the specific symptoms may be 
inappropriate.  
Finally, only one study used a manualised intervention format24, however, the authors did not 
report whether the therapists delivering the intervention were evaluated for adherence to this 
manual. Manualisation provides a standard for delivery of an intervention enabling  
uniformity of treatment delivery. 
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Study limitations 
This systematic review has some limitations. Studies were limited to English language only. 
Due to the paucity of interventional studies targeting cancer-related post-traumatic stress, we 
kept our inclusion criteria broad in terms of the study design and cancer types. As a result, the 
variation between studies makes it difficult to compare treatments and, therefore, to draw any 
firm conclusions. It is for this reason that we could not perform a meta-analysis. Furthermore, 
the studies that were included had considerable methodological weaknesses as discussed 
already. Similarly, in keeping with our broad inclusion criteria, we considered secondary 
findings from subgroups of patients with significant post-traumatic stress symptoms even 
though these were not the study’s primary endpoints.  
The aforementioned methodological issues and limitations in the existing literature give rise 
to recommendations for future research directions. Given the prevalence of PTSS/PTSD in 
cancer patients and the associated burden, it is unclear why there are not more interventional 
studies specifically targeting these symptoms. Well-designed trials are required in order to 
evaluate better the efficacy of well-established treatments such as CBT and EMDR both for 
syndromal and subsyndromal cancer-related PTSD.  Therefore, future studies should pre-
screen for symptoms of cancer-related PTSD using validated tools and follow a consistent 
reporting standard. Finally, a manualised approach to intervention delivery with assessment 
of therapist adherence is recommended in order to promote treatment integrity. 
In order to develop research in this area further, it would be useful to examine the 
comparative efficacy of interventions in patients with different cancer types and with varying 
degrees of cancer-related PTSD symptomatology. Given that in the UK there is a national 
mandate for cancer patients in need of psychological support to be referred to primary care 
mental health services, it may be that routine data from those services could be used in order 
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to monitor the effectiveness of NICE-recommended psychological therapies such as CBT and 
EMDR. For example, the Improving Access to Psychological Therapies (IAPT) service, 
which has been tasked with providing support to patients with cancer, has adopted a clinical 
outcomes monitoring system and data sets are made publicly available35.  
Clinical Implications 
Both CBT and EMDR are recommended by NICE for the treatment and prevention of PTSD 
in adults however there is no specific recommendation for their use in cancer-related PTSD36. 
This article provides evidence to support their effective use in treating cancer-related PTSD. 
Nevertheless, further work needs to be done before a firm recommendation can be made. 
Although PTSD-specific interventions such as CBT and EMDR have shown promising 
results, study numbers were small and there was wide variation in methodology, quality and 
participant characteristics thus limiting the strength of conclusions that can be drawn.  
Furthermore, conceptual issues specific to cancer-related PTSD such as the difficulty in 
pinpointing a specific traumatic event, the unfolding nature of possible stressors and the 
overlap between symptoms of PTSD and other anxiety and mood disorders common amongst 
cancer patients need to be better addressed in future studies assessing the effectiveness of 
treatments for cancer-related PTSD.  
In particular, accuracy in diagnosing cancer-related PTSD relative to other trauma and stress-
related disorders has important treatment implications. For example, a therapy that is 
appropriate for the treatment of cancer-related PTSD (e.g. EMDR) may appear ineffective 
when it is mistakenly administered to patients suffering from adjustment disorder rather than 
cancer-related PTSD.11 Further research is needed in order to understand better the extent to 
which the experience of cancer is traumatogenic and to address diagnostic problems 
pertaining to cancer-related PTSD, taking into account the possibly moderating role of factors 
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such as individual vulnerability to trauma and the availability of supportive resources when 
dealing with cancer 10, 37. Given the beneficial role of social support in aiding adjustment to 
life with and beyond cancer, future studies aiming to understand better the aetiology and 
epidemiology of cancer-related PTSD could also examine the relationship between levels and 
types of cancer-related post-traumatic stress symptoms and the presence of social support.37 
Overall, our findings suggest that existing, empirically validated PTSD treatments such as 
CBT-based therapies and EMDR can be adapted to address cancer-related PTSD with 
comparably promising results. However, methodological limitations of the existing research, 
as well as diagnostic and conceptual difficulties surrounding cancer-related PTSD preclude 
firm recommendations. Further research to address these is likely to have important 
implications for clinical practice by enabling the fine-tuning of existing interventions in order 
to maximise their effective use in oncology settings.  
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Table 1: Studies of cancer-related PTSD interventions-summary of findings 
Author 
Study 
location  
Study characteristics  Diagnoses of PTSD Intervention & 
setting  
Control  PTSD 
measure  
Narrative findings  
EMDR  
Capezzani et 
al (2013)12 
Italy  
 
RCT  
n = 31 
29/31 women 
Mean age range: 50.82 – 
53.40 
Cancer: breast, colon, 
uterus, thyroid, melanoma, 
lung, stomach  
CAPS 
  
EMDR  
Once weekly 
sessions over 8 
weeks 
Individual & face-
to-face 
 
CBT CAPS 
IES-R 
 
 
                                                                                                                                                                                                                                                                                                       
EMDR significantly more effective than 
CBT in particular for reducing intrusive 
symptoms in follow-up cancer patients. 
EMDR also effective in active cancer 
patients.  
Nil dropouts  
 
 
Jarero et al 
(2015)13 
Mexico Before-and-After design  
n= 24 
All women  
Mean age: 54.16 
Cancer: cervical, breast, 
colon, bladder, skin  
SPRINT 
 
PTSD=  > 14  
EMDR-IGTP 
6 sessions over 3 
days  
Group & face-to-
face 
NA  SPRINT Intensive EMDR-IGTP effective for both 
active & follow-up cancer groups with 
cancer-related PTSD 
Nil dropouts 
CBT-based  
DuHamel et al 
(2010)23 
USA RCT 
n = 89 
41/89 women 
Mean age range: 49.38- 
52.19 
CAPS 
PCL-C  
PTSD = 3 or 4 symptom 
cluster criteria on PCL-C, 
or  ≥ 1 SD above mean 
PCL-C, or scores > cut-off 
for 1 symptom cluster on 
T-CBT & workbook 
10 sessions over 10-
16 weeks  
Individual & not-
face-to-face  
Assessment only  PCL-C  
CAPS 
T-CBT participants are less likely to meet 
diagnostic criteria for PTSD at 12 months 
than those is assessment-only group (OR 
0.07, 95% CI 0.006 – 0.88).  
Although T-CBT reduced total PTSD 
symptom scores, it was effective for 
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Cancer: blood-bourne 
malignancy  
 
PCL-C and 2 clinical 
subscales of either BSI or 
BSI Global Severity Index  
intrusive thoughts and avoidance but not for 
numbing and hyperarousal.  
Dropouts 10%. 
Kangas et al 
(2013)24 
Australia  RCT 
n = 35 but 26 with PTSD or 
subthreshold PTSD 
7/35 women 
Mean age: 58.6 
Cancer: Head and neck  
CAPS 
PTSD = 3/3 or 2/3 criteria 
of scale.  
 
 
CBT with HNC-
specific behavioural 
activation.  
Once weekly 
sessions over 6 
weeks with booster 
session at 10 weeks 
Supportive 
counselling  
Once weekly 
sessions over 6 
weeks with booster 
session at 10 weeks 
CAPS Overall, of those with PTSD or sub-
threshold PTSD at baseline, a greater 
proportion of patients in the CBT condition 
had clinically significant improvement at 12 
months compared with the SC group (67% 
versus 20%, F = 2.97, p <0.036). 
Dropouts: CBT arm 48%, SC arm 43%.  
 
 
Beatty and 
Koczwara 
(2010)27 
Australia Case series 
n = 5 
All women  
Mean age 50.2  
Cancer: Breast 
Posttraumatic Stress Scale-
Self Report PSS-SR 
 
PTSD = ≥ 1 re-
experiencing item + ≥ 2 
arousal items, ≥ 3 
avoidance items  
CBSM 
10 sessions over 10 
weeks  
Group & face-to-
face 
NA PSS-SR CBSM partially effective for reducing 
PTSD in breast cancer but did not lead to 
enduring gains. CBSM also negatively 
affects social support and cognitive 
avoidance. 
No dropouts.  
DuHamel et al 
(2000)28 
USA Case study  
n = 1 
Male 
Age: 40  
Cancer: Leukaemia 
DSM-IV SCID trauma-focused 
intervention  
Individual & face-
to-face 
 
NA PCL-C 
IES 
SCID   
Patient no longer met SCID criteria for 
PTSD following assessment. 
PCL-C and IES significantly lower at 1 and 
6 months post-treatment (p < 0.025). 
No dropout.  
Other   
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Marcus et al 
(2010)25 
USA Case series  
n = 304 but do not specify 
number with significant 
PTSD 
All women 
Half sample < 50 years   
Cancer: breast  
IES (intrusion subscale 
only) 
 
High risk of PTSD = score 
> 20  
telephone 
counselling 
programme + 
resource booklet 
16 sessions over 12 
months  
Individual & not 
face-to-face  
 
resource booklet 
only  
 
IES - only 
intrusion 
subscale 
Significant reduction in cancer-related 
distress in participants scoring high levels of 
distress at baseline in the telephone 
counselling group  compared to no change 
in those given only the resource book 
(Effect size 0.5). 
Dropouts at 6 months 12%, 12 months 14%. 
Levine et al 
(2005)26 
USA 
 
RCT 
n =181 but 26 with 
significant PTSD 
All women  
Mean age: 45 (of all 
participants)  
Cancer: breast  
PCL-C  
 
PTSD =  combined cut-off 
of > 44 and cluster method  
 
CAM – involved 
yoga, meditation, 
imagery & 
expressive arts 
Twice weekly 
sessions over 12 
weeks  
Group & face-to-
face  
Standard support 
group – unstructured 
psychoeducational 
support group 
Once weekly 
sessions over 12 
weeks.  
Group & face-to-
face 
PCL-C  PTSD more improved in standard support 
group versus CAM group however QOL 
more improved in CAM group.  
No dropouts for subgroup with significant 
PTSD symptoms. 
 
CAPS = Clinician-Administered PTSD Scale, PTSD = post-traumatic stress disorder, RCT = randomised controlled trial, EMDR = Eye-movement desensitisation and 
reprocessing therapy, CBT = Cognitive behavioural therapy, IES-R = revised Impact of Events Scale, SPRINT = short PTSD rating interview, IGTP = integrative group 
treatment protocol, HNC = head and neck cancer, PCL-C = PTSD Checklist, T-CBT = telephone CBT, PSS-SR = Posttraumatic Stress Scale-Self Report, CBSM = Cognitive 
Behaviour Stress Management, DSM-IV SCID = Structured Clinical Interview for he Diagnostic and Statistical Manual of Mental Disorders, CAM = Complementary/ 
alternative intervention programme, QOL = quality of life 
 
 
 
  
This article is protected by copyright. All rights reserved. 
Table 2: Quality assessment  
 
Study Quality Tool  Quality Rating 
Capezzani et al (2013)11 Cochrane  Unclear risk of bias  
Jarero et al (2015)12 NIH Quality Assessment Tool  Poor  
DuHamel et al (2010)23 Cochrane  Unclear risk of bias  
Kangas et al (2013)24 Cochrane  High risk of bias 
Marcus et al (2010)25 Cochrane  High risk of bias 
Levine et al (2005)26 Cochrane  High risk of bias 
Beatty and Koczwara (2010)27 NIH Quality Assessment Tool  Fair 
DuHamel et al (2000)28 NA  NA  
 
NIH = National Institutes of Health.  
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